What is the difference between Indica, Sativa, and CBD heavy strains?
CBD is one of the 85+ cannabinoids found in cannabis. Unlike THC, on average it has no psychoactive properties. Current medical studies suggest that it has medical applications to conditions such as epilepsy, anxiety, bipolar disorder, nausea, convulsion and inflammation, and multiple sclerosis spasms. It has also been observed inhibiting cancer cell growth.
In layman’s terms, CBD is more medical and less intoxicating.
Unlike CBD, the term Sativa doesn’t always refer to a balance of cannabinoids in the plant. The two terms Indica and Sativa refer to differences in genetic breeding. Sativa dominant marijuana strains tend to grow taller and thinner, with a grassier smell to them.
Sativa strains are thought to be better for mental cognition.
Effects attributed to Sativas include:
Energy to accomplish tasks
Patients report using Sativas strains when they need medication during the day and need to be productive in a variety of environments. The chemical composition of Sativas generally are higher in THC with little to low levels of CBD.
Indica dominant strains tend to be shorter and thicker, better for confined spaces such as indoor grows. They often have a sweet or sour oder. Cannabis Indica have a broader thicker leaf that distinguish them from the Cannabis Sativa plant.
Indica strains are thought to be better for physical pain and relaxation.
Effects attributed to Indicas include:
Treatment for headaches and migraines
Relief from spasms and seizures
Reduced Anxiety and Stress
Patients report using Indicas when they need to go to sleep at night and don’t have to be highly functional. The chemical composition of Indicas are generally made up of moderate levels of THC and CBD.
El-Alfy, Abir T, et al. (Jun 2010). “Antidepressant-like effect of delta-9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.”. Pharmacology Biochemistry and Behavior 95 (4): 434–42. doi:10.1016/j.pbb.2010.03.004. PMC 2866040. PMID 20332000.
Grlić, Ljubiša (1962). “A comparative study on some chemical and biological characteristics of various samples of cannabis resin”. Bulletin on Narcotics (UNODC) (3): 37–46.
Ashton, CH; Moore, PB; Gallagher, P; Young, AH (May 2005). “Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential”. Journal of Psychopharmacology 19 (3): 293–300. doi:10.1177/0269881105051541. PMID 15888515.
Jones, N. A.; Glyn, S. E.; Akiyama, S.; Hill, T. D. M.; Hill, A. J.; Weston, S. E.; Burnett, M. D. A.; Yamasaki, Y.; Stephens, G. J.; Whalley, B. J.; Williams, C. M. (2012). “Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures”. Seizure 21 (5): 344–352. doi:10.1016/j.seizure.2012.03.001. PMID 22520455.
Kozela, E.; Lev, N.; Kaushansky, N.; Eilam, R.; Rimmerman, N.; Levy, R.; Ben-Nun, A.; Juknat, A.; Vogel, Z. (2011). “Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice”. British Journal of Pharmacology 163 (7): 1507–1519. doi:10.1111/j.1476-
a b c McAllister SD, Christian RT, Horowitz MP, Garcia A, Desprez PY (2007). “Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells”. Mol. Cancer Ther. 6 (11): 2921–7. doi:10.1158/1535-7163.MCT-07-0371. PMID 18025276.
“Difference Marijuana Cannabis Sativa and Indica, Sativa or Indica Marijuana Seed Strains.”. Amsterdam Marijuana Seeds Seed Bank.